Villers-lès-Nancy, 7 July 2015 - 18:00 (CET)
PRESS RELEASE
Division of PHARMAGEST INTERACTIVE's nominal share value
PHARMAGEST INTERACTIVE announced that in order to increase stock liquidity and continue to diversify its shareholder base, the Extraordinary General Meeting of Shareholders dated 26 June 2015 decided to divide PHARMAGEST INTERACTIVE's nominal share value by five (5). This share split will be effective as of 5 August 2015. Therefore, for any existing share with a nominal value of €1 held on that date, in exchange, the shareholders will receive five new shares with a nominal value of €0.20.
The division of the nominal share value will be effective when the market opens on 5 August 2015. On this date, the total share capital will be multiplied by five and PHARMAGEST INTERACTIVE's share price will trade on the basis of the opening share price of 5 August 2015 divided by five.
Therefore, the share capital will be divided into 15,174,125 shares of €0.20 each, all of the same class, compared with 3,034,825 shares of €1 currently.
This transaction will be carried out without any costs or formalities for PHARMAGEST INTERACTIVE's shareholders and will have no impact on their rights.
About the PHARMAGEST Group:
The PHARMAGEST Group is the French leader in information technology for pharmacies, with a 43.5% market share, 9,800 clients and more than 800 employees. Since September 2007, the PHARMAGEST Group is also present in Northern Europe with a 12% market share in Belgium and Luxembourg through its subsidiary SABCO.
As a partner of choice for pharmacists for almost 30 years, the PHARMAGEST Group designs innovative computer solutions for pharmacies and is developing a high-potential E-Business E-Media activity intended for pharmaceutical companies.
The PHARMAGEST Group is also developing innovative new solutions for Retirement Homes (care homes and day centres for the elderly) through its subsidiary MALTA INFORMATIQUE.
The first Logiciel de Gestion à Portail Intégré (Integrated Portal Management Software - LGPI Global Services®), creates value for patients, pharmacists and pharma companies alike, boosts sales, optimises purchases and improves advice offered to patients. It is also the first permanent-impact medium for pharmacies that provides pharmaceutical companies with a direct means of communication with pharmacists and their patients.
The PHARMAGEST Group is a key player in the digital revolution affecting the daily lives of healthcare professionals and patients. Early in 2012, the Group set up an e-Health business comprising DIATELIC (telemedicine and e-health solutions) and DOMEDIC EUROPE (DO-Pill SecuR(TM) intelligent pill dispenser) and KAPELSE (connected Health devices).
Listed on the NYSE Euronext Paris(TM) - Compartment B
CAC ® SMALL and CAC ® All-Tradable indices by inclusion
Eligible for the Long-Only Deferred Settlement Service (SRD)
ISIN: FR 0000077687 - Reuters: PHA.PA - Bloomberg: - PMGI FP
PHARMAGEST shares are eligible for France's Equity Savings Plan intended to finance SMEs (PEA-PME)
For all the latest news, go to www.pharmagest.com
CONTACTS
Analyst and Investor Relations:
Chief Administrative and Financial Officer: Jean-Yves Samson
Tel. +33 (0)3 83 15 90 67 - jean-yves.samson@pharmagest.com
Press relations:
FIN'EXTENSO - Isabelle Aprile
Tel. +33 (0)1 39 97 61 22 - i.aprile@finextenso.fr
